鞘氨醇-1-磷酸:新生血管性视网膜疾病的潜在靶点
本文综述鞘氨醇-1-磷酸(S1P)作为新生血管性眼病(如年龄相关性黄斑变性、糖尿病视网膜病变和视网膜静脉阻塞)潜在治疗靶点的作用。S1P通过五种G蛋白偶联受体(S1P1-5)介导血管生成、炎症、凋亡和纤维化等过程,其中S1P1受体激活可减少血管生成并保护视网膜,而S1P2受体信号则促进新生血管形成和神经视网膜退行性变。
要点
- S1P1受体激活可减少血管生成、增强内皮完整性并减少光感受器凋亡。
- S1P2受体信号促进新生血管形成、破坏内皮连接并诱导视网膜细胞凋亡。
- S1P及其受体亚型在血管生成、炎症、凋亡和纤维化中作用不同,可作为治疗靶点。
核心结论
- S1P是治疗新生血管性眼病的潜在药理靶点,其不同受体亚型在血管生成、炎症、凋亡和纤维化中的作用为治疗干预提供了方向。
研究设计与样本
- 本文为综述,讨论S1P及其不同受体亚型在新生血管性眼病血管生成、炎症、凋亡和纤维化中的作用,以确定可靶向治疗的S1P介导过程。
主要发现
- S1P1受体激活可减少血管生成、增加内皮完整性、减少光感受器凋亡并保护视网膜免受神经退行性变。
- S1P2受体信号可增加新生血管形成、破坏内皮连接、刺激VEGF释放并诱导视网膜细胞凋亡和神经视网膜退行性变。
- S1P作用于五种G蛋白偶联受体(S1P1-5),这些受体在视网膜和视网膜下结构中丰富表达。
关键数值与推荐
- S1P1受体激活:减少血管生成、增加内皮完整性、减少光感受器凋亡、保护视网膜免受神经退行性变。
- S1P2受体信号:增加新生血管形成、破坏内皮连接、刺激VEGF释放、诱导视网膜细胞凋亡和神经视网膜退行性变。
临床怎么用
- 目前抗VEGF治疗需频繁玻璃体腔注射且价格昂贵、伴多种不良反应,S1P及其受体亚型可能成为副作用更少的替代治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neovascular ocular diseases (such as age-related macular degeneration, diabetic retinopathy and retinal vein occlusion) are characterised by common pathological processes that contribute to disease progression. These include angiogenesis, oedema, inflammation, cell death and fibrosis. Currently available therapies target the effects of vascular endothelial growth factor (VEGF), the main mediator of pathological angiogenesis. Unfortunately, VEGF blockers are expensive biological therapeutics that necessitate frequent intravitreal administration and are associated with multiple adverse effects. Thus, alternative treatment options associated with fewer side effects are required for disease management. This review introduces sphingosine 1-phosphate (S1P) as a potential pharmacological target for the treatment of neovascular ocular pathologies. S1P is a sphingolipid mediator that controls cellular growth, differentiation, survival and death. S1P actions are mediated by five G protein-coupled receptors (S1P1-5 receptors) which are abundantly expressed in all retinal and subretinal structures. The action of S1P on S1P1 receptors can reduce angiogenesis, increase endothelium integrity, reduce photoreceptor apoptosis and protect the retina against neurodegeneration. Conversely, S1P2 receptor signalling can increase neovascularisation, disrupt endothelial junctions, stimulate VEGF release, and induce retinal cell apoptosis and degeneration of neural retina. The aim of this review is to thoroughly discuss the role of S1P and its different receptor subtypes in angiogenesis, inflammation, apoptosis and fibrosis in order to determine which of these S1P-mediated processes may be targeted therapeutically.
引用
- Alshaikh RA, Ryan KB, Waeber C, et al. Sphingosine 1-phosphate, a potential target in neovascular retinal disease. Br J Ophthalmol. 2021. PMID: 33962970. doi:10.1136/bjophthalmol-2021-319115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。